An enzyme-linked immunosorbent spot (ELISpot) assay was first described over 25 years ago. Since then, it has become one of the most common immunoassays, used in human clinical trials for vaccines and other forms of immunotherapy. The number of publications based on this methodology has risen exponentially. If you are considering the use of the […]